MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Mechanisms and Consequences of Weight Gain After Deep Brain Stimulation of the Subthalamic Nucleus in Patients with Parkinson’s Disease

J. Steinhardt, L. Lokowandt, D. Rasche, V. Tronnier, T. Münte, S. Meyhöfer, B. Wilms, N. Brüggemann (Lübeck, Germany)

Meeting: 2022 International Congress

Abstract Number: 341

Keywords: Neurostimulation, Parkinson’s, Subthalamic nucleus(SIN)

Category: Surgical Therapy: Parkinson's Disease

Objective: To identify stimulation-dependent effects of deep brain stimulation (DBS) on body weight and energy metabolism depending on the electrode position within the subthalamic nucleus (STN).

Background: A remarkable body weight gain in combination with metabolic alterations has been observed after STN DBS in patients with Parkinson’s disease (PD), which potentially counteracts the positive effects of motor improvement.

Method: Fourteen PD patients who underwent STN DBS (PD-DBS) were assessed before, 6 and 12 months post-surgery. For control purposes, 18 PD patients under best medical treatment (PD-CON) and 25 healthy controls (H-CON) were enrolled. Wrist actigraphy, assessment of body composition, analysis of hormones, and energy expenditure measurements were applied. Electrode placement in the STN was localized using a state-of-the-art approach.

Results: STN DBS resulted in a mean improvement of motor function of 60.9±2.6% after 6 months of stimulation and remained stable over stimulation duration (DBS ON, Med ON). Body weight and fat mass increased by +2.9 kg and 2.7% in PD-DBS (all p≤0.01) after 6 months of stimulation. After 12 months of stimulation, body weight increased by +3.2 kg (p=0.011) and FM increased to 2.8% (p=0.001) compared to baseline. On a metabolic level, we found increased levels of insulin (p=0.05) as well as an increased HOMA index (insulin resistance measurement; p=0.04) in DBS-treated patients but not in the control groups after 6 months of DBS. Moreover, growth hormone levels decreased after 6 months of stimulation (p=0.03). Decreased levels of daily physical activity and decreased VO2 levels during walking were exclusively found in PD-DBS group after 6 months of stimulation (all p≤0.01). Activity levels remained on a low level after 12 months of stimulation. DBS of the limbic proportion of the STN was associated with changes in body composition, glucose homeostasis and decreased energy output (all p≤0.04; all r≥0.56).

Conclusion: Our results highlight that physical activity is decreased after STN DBS in PD which contributes to weight gain and an unfavorable metabolic profile. We recommend measurements of the body weight on a regular basis and the use actigraphy devices to provide feedback on the daily activity. This approach could help the patient to achieve pre-defined activity goals, e.g. number of steps per day.

To cite this abstract in AMA style:

J. Steinhardt, L. Lokowandt, D. Rasche, V. Tronnier, T. Münte, S. Meyhöfer, B. Wilms, N. Brüggemann. Mechanisms and Consequences of Weight Gain After Deep Brain Stimulation of the Subthalamic Nucleus in Patients with Parkinson’s Disease [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/mechanisms-and-consequences-of-weight-gain-after-deep-brain-stimulation-of-the-subthalamic-nucleus-in-patients-with-parkinsons-disease/. Accessed July 9, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/mechanisms-and-consequences-of-weight-gain-after-deep-brain-stimulation-of-the-subthalamic-nucleus-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley